yingweiwo

New7

New7

New7 related products

Structure Cat No. Product Name CAS No. Product Description
PI3Kγ inhibitor 2 V4980 PI3Kγ inhibitor 2 1315538-79-4 PI3Kγ inhibitor 2 (Compound 16 in referenceJ Med Chem.
PI3kδ inhibitor 1 V4992 PI3kδ inhibitor 1 1332075-63-4 PI3kδ inhibitor 1 is a novel, potent and selectivePI3Kδinhibitor with anIC50of 3.8 nM.
PI3Kδ-IN-1 V4969 PI3Kδ-IN-1 1911564-39-0 PI3Kδ-IN-1 is a novel, potent, selective, and efficacious PI3Kδ inhibitor with an IC50of 1.7 nM.
PI4KIII beta inhibitor 3 V4987 PI4KIII beta inhibitor 3 1245319-54-3 PI4KIII beta inhibitor 3, extracted fromWO 2013034738 A1, is a novel and potent PI4KIIIβ inhibitor with IC50of 5.7 nM.
PQR-530 V4756 PQR-530 1927857-61-1 PQR-530 is a novel, potent, orally bioavailable and brain-penetrant dual pan-PI3K/mTORC1/2inhibitor, it exhibits antitumor activity.
PR-104 V4984 PR-104 851627-62-8 PR-104, a novel, potent, non-toxic, small-molecule, hypoxia-activated, 3,5-dinitrobenzamide nitrogen mustard, is a drug from the class of hypoxia-activated prodrugs (HAPs), which is being researched as a potential anti-cancer therapeutic agent.
PROTAC ABL结合部分2 V4535 PROTAC ABL binding moiety 2 778277-37-5 PROTAC ABL binding moiety 2 is the GNF5 (an ABL inhibitor) moiety that binds to IAP (inhibitor of apoptosis protein) ligand via a linker to form SNIPER.
PROTAC BET Degrader-3 V4742 PROTAC BET Degrader-3 PROTAC BET Degrader-3 is a PROTAC protein degrader linked by von Hippel-Lindau ligand and BET ligand.
PROTAC-PEG3-Amino V4744 PROTAC-PEG3-Amino 189808-70-6 NH2-PEG3-C1-Boc (PROTAC (PROteolysis TArgeting Chimera) linker 5) is a PROTAC (PROteolysis TArgeting Chimera) linker of the Polyethylene glycol (PEG) category.
PROTAC-PEG3-Benene sulfonyl V4745 PROTAC-PEG3-Benene sulfonyl 1246999-33-6 Tos-PEG4-NH-Boc (PROTAC (PROteolysis TArgeting Chimera) linker 7) is a PROTAC (PROteolysis TArgeting Chimera) linker of the Polyethylene glycol (PEG) category.
PRX933 HCl V4954 PRX933 HCl 639029-42-8 PRX933 HCl, the hydrochloride salt form of PRX933 which is extracted from patent WO 2014140631 A1, is a novel and potent 5-HT2creceptor agonist
PTC299 V4687 PTC299 1256565-36-2 PTC-299 (PTC299; PTC 299) is a novel, potent and orally bioavailableVEGFinhibitorwith potential antiangiogenesis and antineoplastic activities.
Rimeporid (EMD 87580) V5164 Rimeporid (EMD 87580) 187870-78-6 Rimeporide (also known as EMD-87580) is a novel, potent and selective inhibitor of the sodium/hydrogen Na+/H+exchanger (NHE-1) with a potential to be used as a therapeutic agent for the treatment of heart failure and for patients with Duchenne muscular dystrophy.
S-8510 V4624 S-8510 151224-83-8 S-8510 (SB-737552) is a novel and potent partial inverseBenzodiazepine (BDZ) receptoragonist, with Kis of 34.6 nM, 36.2 nM for –GABA and +GABA respectively.
San78-130 V4736 San78-130 66018-45-9 San78-130 is a novel, potent and selectiveALK1inhibitor with anIC50of 62 nM.
SB 258719 V4606 SB 258719 195199-95-2 SB 258719 (SB-258719) is a novel, potent and selective5-HT7receptorantagonist with apKiof 7.5.
SB-423562 V4616 SB-423562 351490-72-7 SB-423562 is a novel and potent short-acting calcium-sensing receptor(CaR)antagonist.
SB-568849 V4619 SB-568849 395679-53-5 SB-568849 is a novel and potent melanin-concentrating hormone receptor 1(MCH R1) antagonist with apKiof 7.7.
SB-616234A V4621 SB-616234A 908601-49-0 SB-616234A is a novel, potent, selective and orally bioavailable5-HT1B receptorantagonist, with anxiolytic and antidepressant activity.
SB-7720770 2HCl V4620 SB-7720770 2HCl 607373-46-6 SB-772077B dihydrochloride (also known as SB-772077-B; SB-772077) is a novel and potent aminofurazan-basedRho kinase( ROCK)inhibitor withIC50s of 5.6 nM and 6 nM toward ROCK1 and ROCK2, respevtively.
Contact Us